The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCOLADE INC | COM | 00437E102 | 1,318 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AGILON HEALTH INC | COM | 00857U107 | 4,050 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 11,973 | 514,082 | SH | SOLE | 514,082 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 4,621 | 1,155,300 | SH | SOLE | 1,155,300 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,411 | 31,907 | SH | SOLE | 31,907 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 4,182 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 5,833 | 15,481 | SH | SOLE | 15,481 | 0 | 0 | ||
COGNITION THERAPEUTICS INC | COM | 19243B102 | 1,909 | 301,979 | SH | SOLE | 301,979 | 0 | 0 | ||
CONVEY HEALTH SOLUTIONS HLDG | COM | 21258C108 | 6,496 | 777,000 | SH | SOLE | 777,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 1,316 | 17,364 | SH | SOLE | 17,364 | 0 | 0 | ||
CUE BIOPHARMA INC | COM | 22978P106 | 9,376 | 829,042 | SH | SOLE | 829,042 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 564 | 166,775 | SH | SOLE | 166,775 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 7,974 | 122,187 | SH | SOLE | 122,187 | 0 | 0 | ||
EXICURE INC | COM | 30205M101 | 490 | 2,426,508 | SH | SOLE | 2,426,508 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 19,069 | 345,900 | SH | SOLE | 345,900 | 0 | 0 | ||
GALAPAGOS NV | CALL | 36315X901 | 11,043 | 200,300 | SH | Call | SOLE | 200,300 | 0 | 0 | |
GLOBUS MED INC | CL A | 379577208 | 1,458 | 20,188 | SH | SOLE | 20,188 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,313 | 68,800 | SH | SOLE | 68,800 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,419 | 409,620 | SH | SOLE | 409,620 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 6,019 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 940 | 3,700 | SH | SOLE | 3,700 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 3,454 | 72,898 | SH | SOLE | 72,898 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 404 | 298,900 | SH | SOLE | 298,900 | 0 | 0 | ||
OSCAR HEALTH INC | CL A | 687793109 | 7,261 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 1,900 | 195,855 | SH | SOLE | 195,855 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 500 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
PROGYNY INC | PUT | 74340E953 | 2,518 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 2,857 | 356,617 | SH | SOLE | 356,617 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 21,785 | 441,000 | SH | SOLE | 441,000 | 0 | 0 | ||
PROTHENA CORP PLC | CALL | G72800908 | 2,574 | 52,100 | SH | Call | SOLE | 52,100 | 0 | 0 | |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 2,810 | 128,705 | SH | SOLE | 128,705 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 2,215 | 260,243 | SH | SOLE | 260,243 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 358 | 53,815 | SH | SOLE | 53,815 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 1,035 | 802,180 | SH | SOLE | 802,180 | 0 | 0 | ||
WEST PHARMACEUTICAL SVSC INC | PUT | 955306955 | 704 | 1,500 | SH | Put | SOLE | 1,500 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 5,897 | 362,909 | SH | SOLE | 362,909 | 0 | 0 |